Related Experiment Videos
[A rational selection of retroperitoneal lymphadenectomy for advanced epithelial ovarian cancer]
Objective:
To evaluate the rational application of retroperitoneal lymphadenectomy to advanced epithelial ovarian cancer.
Methods:
42 patients of advanced epithelial ovarian cancer were treated by retroperitoneal lymphadenectomy. Two groups were divided according to the residual disease post-operation. A: 26 patients with the residual disease < 2 cm; B: 16 patients > or = 2 cm. The regime of combined chemotherapy was the same in the two groups after operation. Clinical stage and pathologic grade showed no difference.
Results:
The 5-year survival rate was 53.8% (14/26) in A and 12.5% (2/16) in B. There was a significant difference between the two groups (P < 0.001).
Conclusions:
The survival rate could be greatly improved for advanced epithelial ovarian cancer through retroperitoneal lymphadenectomy when the residual disease was smaller than 2 cm. This procedure would not be performed if the residual disease was larger than or equal to 2 cm.